AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 163 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $130,904 | +11.7% | 31,020 | -63.2% | 0.00% | – |
Q1 2023 | $117,188 | +155.4% | 84,308 | +265.7% | 0.00% | – |
Q4 2022 | $45,883 | -73.9% | 23,057 | -58.3% | 0.00% | -100.0% |
Q2 2022 | $176,000 | -53.4% | 55,303 | -39.0% | 0.00% | -50.0% |
Q1 2022 | $378,000 | +51.2% | 90,608 | +73.3% | 0.00% | +100.0% |
Q4 2021 | $250,000 | -15.3% | 52,287 | -5.5% | 0.00% | 0.0% |
Q3 2021 | $295,000 | -22.8% | 55,326 | -25.8% | 0.00% | 0.0% |
Q2 2021 | $382,000 | -10.1% | 74,599 | -19.8% | 0.00% | -66.7% |
Q4 2020 | $425,000 | -33.1% | 93,034 | -43.2% | 0.00% | -66.7% |
Q3 2020 | $635,000 | +1033.9% | 163,757 | +1296.1% | 0.01% | +800.0% |
Q2 2020 | $56,000 | -58.2% | 11,730 | -69.5% | 0.00% | -66.7% |
Q1 2020 | $134,000 | -93.1% | 38,437 | -90.5% | 0.00% | -75.0% |
Q4 2019 | $1,942,000 | +63.3% | 402,908 | -1.7% | 0.01% | +9.1% |
Q3 2019 | $1,189,000 | -70.7% | 410,003 | +43.0% | 0.01% | -74.4% |
Q1 2019 | $4,064,000 | +325.5% | 286,808 | +306.5% | 0.04% | +290.9% |
Q4 2018 | $955,000 | – | 70,557 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
PA Capital LLC | 33,874 | $132,000 | 0.09% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |